Wikidata

(Q34756419)

English

Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).

scientific article

In more languages

Statements

title
Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18306243
retrieved
4 August 2017
author name string
Peter A LeWitt
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
18306243
retrieved
4 August 2017
James W Tetrud
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
18306243
retrieved
4 August 2017
Paul J Tuite
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
18306243
retrieved
4 August 2017
Akihisa Mori
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
18306243
retrieved
4 August 2017
Philip Chaikin
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
18306243
retrieved
4 August 2017
Neil M Sussman
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
18306243
retrieved
4 August 2017
6002-US-005 Study Group
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
18306243
retrieved
4 August 2017
cites work

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34756419&oldid=1839333553"